Capital Fund Management (CFM)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$544K	Buy	+57,138	New	+$444K	﹤0.01%	1857
2025 Q3	–	Sell	-51,913	Closed	-$465K	–	2474
2025 Q2	$465K	Buy	+51,913	New	+$483K	0.01%	2205
2025 Q1	–	Sell	-59,327	Closed	-$446K	–	2021
2024 Q4	$446K	Sell	59,327 -298,288	-83%	-$2.26M	﹤0.01%	1928
2024 Q3	$2.72M	Buy	357,615 +110,075	+44%	+$837K	0.03%	1289
2024 Q2	$1.53M	Buy	247,540 +36,009	+17%	+$199K	0.02%	1482
2024 Q1	$1.07M	Buy	+211,531	New	+$1.19M	0.01%	1688
2023 Q4	–	Sell	-122,778	Closed	-$869K	–	2136
2023 Q3	$869K	Sell	122,778 -46,910	-28%	-$337K	0.01%	1686
2023 Q2	$1.19M	Buy	169,688 +104,394	+160%	+$838K	0.02%	1353
2023 Q1	$545K	Buy	+65,294	New	+$629K	0.01%	1432
2022 Q2	–	Sell	-117,505	Closed	-$1.91M	–	1434
2022 Q1	$1.91M	Buy	+117,505	New	+$1.88M	0.05%	965
2021 Q4	–	Hold	0	–	–	–	1613
2014 Q3	–	Sell	-38,904	Closed	-$496K	–	1525
2014 Q2	$496K	Buy	+38,904	New	+$379K	0.01%	1215